Exosomes derived from DCs can activate T cells and NK cells to enhance the killing effect on tumor cells, while those released by NK cells include FASL, perforin, and NKG2D, which can kill tumor cells in vitro (280). The gene discussed is KLRK1; the disease is neoplasm.